Diederik J. Grootendorst

First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations

Luis Paz‐Ares, Tudor–Eliade Ciuleanu, Manuel Cobo et al. · Journal of Thoracic Oncology · 2022 · 92 citations

Evaluation of superparamagnetic iron oxide nanoparticles (Endorem®) as a photoacoustic contrast agent for intra‐operative nodal staging

Diederik J. Grootendorst, Jithin Jose, Raluca M. Fratila et al. · Contrast Media & Molecular Imaging · 2012 · 78 citations · Full text

Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

Martin Reck, Tudor–Eliade Ciuleanu, Jong-Seok Lee et al. · Journal of Thoracic Oncology · 2023 · 67 citations · Full text

Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial

Martin Reck, Tudor–Eliade Ciuleanu, Michael Schenker et al. · European Journal of Cancer · 2024 · 57 citations

First experiences of photoacoustic imaging for detection of melanoma metastases in resected human lymph nodes

Diederik J. Grootendorst, J. Jose, Michel W.J.M. Wouters et al. · Lasers in Surgery and Medicine · 2012 · 50 citations